LISANTI MICHAEL P has a total of 19 patent applications. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are INST OF BASIC MEDICINE SAMS, GKH PHARMACEUTICAL LTD and ANDA BIOLOG SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 10 | |
#2 | United States | 7 | |
#3 | EPO (European Patent Office) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Organic fine chemistry | |
#5 | Computer technology | |
#6 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Analysing materials | |
#3 | Measuring microorganism processes | |
#4 | Therapeutic chemical compounds | |
#5 | Computational chemistry | |
#6 | Heterocyclic compounds | |
#7 | Peptides | |
#8 | Animal care | |
#9 | Microorganisms | |
#10 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Lisanti Michael P | 16 |
#2 | Sotgia Federica | 16 |
#3 | Pestell Richard G | 6 |
#4 | Lisanti Michael | 3 |
#5 | Federica Sotgia | 1 |
#6 | Jasmin Jean-Francois | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019005698A1 | Mitoketoscins: mitochondrial-based therapeutics targeting ketone metabolism in cancer cells | |
US2015240240A1 | Msf reprograms myofibroblasts toward lactate production and fuel anaerboic tumor growth | |
WO2012166700A2 | Molecular profiling of a lethal tumor microenvironment | |
WO2012135397A2 | Lactate-and ketones-induced gene signatures and use the same for diagnosing disease and predicting clinical outcome | |
US2014026234A1 | Biomarkers and their uses in cancer detection and therapy | |
US2013172430A1 | Prognosis and treatment of breast cancer | |
US2012039805A1 | Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample | |
EP3021120A1 | Diagnosis, prognosis, therapeutics and methods for treating neoplastic deiseases comprising determining the level of caveolin-1 in a stromal cell sample | |
US2009068258A1 | Caveolin-mimetic peptide for prevention and treatment of pulmonary hypertension and right ventricular hypertrophy |